Washington/Chicago/Berlin — Bayer won US antitrust approval for its $66bn takeover of Monsanto, clearing the last major regulatory hurdle to forming the world’s biggest seed and agricultural-chemicals provider, after a nearly two-year global review. The companies reached a settlement with the US Justice Department that resolves the government’s concern that the merger, as initially structured, would harm consumers and farmers, the US said on Tuesday. The agreement requires the sale of assets to BASF that Bayer has previously announced. The divestiture package was worth about $9bn, the largest in a US merger enforcement case, the government said. "America’s farm system is of critical importance to our economy, to our food system, and to our way of life," Makan Delrahim, the head of the department’s antitrust division, said on a call with reporters. "American farmers and consumers rely on head-to-head competition between Bayer and Monsanto." For Bayer, acquiring Monsanto is the last s...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.